Evidence map›Paper›PMID 42755520›Full record

SynthesisFrontiers in medicine2026

Artificial intelligence in personalized computed tomography dose optimization: a systematic review of techniques and clinical outcomes.

Nora Almuqbil

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nora AlmuqbilDepartment of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Artificial intelligence (AI) for personalized computed tomography (CT) dose optimization has gained increasing attention due to its potential to reduce radiation exposure while maintaining image quality. CT dose optimization tailors according to individual patient characteristics, including age, weight, body composition, and clinical condition. The study aims to evaluate AI techniques in CT dose optimization, focusing on reducing radiation exposure while maintaining image quality. Methods: The relevant studies published between 2010 and 2024 were screened from databases, such as PubMed, IEEE Xplore, Scopus, ScienceDirect, and Web of Science, by following "Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)" guidelines and "Population, Intervention, Comparison, and Outcome ( Results: The review underscores the significance of deep learning (DL) and machine learning (ML) algorithms, including reconstructive strategies, predictive modeling, and hybrid models, as critical in enhancing dose optimization. Conclusion: AI-driven approaches in CT dose optimization show promising potential to reduce radiation exposure safely and effectively without compromising image quality. Future research necessitating larger, diverse clinical trials are essential to validate these findings and ensure the equitable application of AI technologies across varied patient demographics. Studies have consistently indicated AI's potential to reduce the dose exposure while maintaining the image and diagnostic quality. They highlight the importance of DL- and ML-based algorithms, such as reconstructive strategies, predictive modeling, and hybrid models, in CT dose optimization.

Indexed as

artificial intelligencecomputed tomographyimage qualitypersonalized doseradiation dose reduction

Identifiers

PMID42755520
PMCPMC13581678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.